Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 274

Similar articles for PubMed (Select 23637971)


S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway.

Duan L, Wu R, Ye L, Wang H, Yang X, Zhang Y, Chen X, Zuo G, Zhang Y, Weng Y, Luo J, Tang M, Shi Q, He T, Zhou L.

PLoS One. 2013 Apr 26;8(4):e62092. doi: 10.1371/journal.pone.0062092. Print 2013. Erratum in: PLoS One. 2013;8(5). doi:10.1371/annotation/61e0cb2d-6d8c-41d7-99f2-d1b97581e207.


Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.

Ang CW, Nedjadi T, Sheikh AA, Tweedle EM, Tonack S, Honap S, Jenkins RE, Park BK, Schwarte-Waldhoff I, Khattak I, Azadeh B, Dodson A, Kalirai H, Neoptolemos JP, Rooney PS, Costello E.

Carcinogenesis. 2010 Sep;31(9):1541-51. doi: 10.1093/carcin/bgq137. Epub 2010 Jul 9.


Identification of S100A8 and S100A9 as serological markers for colorectal cancer.

Kim HJ, Kang HJ, Lee H, Lee ST, Yu MH, Kim H, Lee C.

J Proteome Res. 2009 Mar;8(3):1368-79. doi: 10.1021/pr8007573.


Astrocyte elevated gene-1 interacts with β-catenin and increases migration and invasion of colorectal carcinoma.

Zhang F, Yang Q, Meng F, Shi H, Li H, Liang Y, Han A.

Mol Carcinog. 2013 Aug;52(8):603-10. doi: 10.1002/mc.21894. Epub 2012 Mar 16.


Identification of S100A8 and S100A9 as negative regulators for lymph node metastasis of gastric adenocarcinoma.

Choi JH, Shin NR, Moon HJ, Kwon CH, Kim GH, Song GA, Jeon TY, Kim DH, Kim DH, Park do Y.

Histol Histopathol. 2012 Nov;27(11):1439-48.


S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.

Hermani A, De Servi B, Medunjanin S, Tessier PA, Mayer D.

Exp Cell Res. 2006 Jan 15;312(2):184-97. Epub 2005 Nov 17.


S100A8/A9 induces apoptosis and inhibits metastasis of CasKi human cervical cancer cells.

Qin F, Song Y, Li Z, Zhao L, Zhang Y, Geng L.

Pathol Oncol Res. 2010 Sep;16(3):353-60. doi: 10.1007/s12253-009-9225-2. Epub 2009 Dec 3.


ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.

Shin HW, Choi H, So D, Kim YI, Cho K, Chung HJ, Lee KH, Chun YS, Cho CH, Kang GH, Kim WH, Park JW.

Gastroenterology. 2014 Aug;147(2):430-442.e8. doi: 10.1053/j.gastro.2014.04.047. Epub 2014 May 15.


S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast.

Arai K, Takano S, Teratani T, Ito Y, Yamada T, Nozawa R.

Curr Cancer Drug Targets. 2008 Jun;8(4):243-52.


[Expression of Wnt5a, APC, β-catenin and their clinical significance in human colorectal adenocarcinoma].

Cao YC, Yang F, Liu XH, Xin X, Wang CC, Geng M.

Zhonghua Zhong Liu Za Zhi. 2012 Sep;34(9):674-8. doi: 10.3760/cma.j.issn.0253-3766.2012.09.007. Chinese.


The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment.

Kim JH, Oh SH, Kim EJ, Park SJ, Hong SP, Cheon JH, Kim TI, Kim WH.

Biochem Biophys Res Commun. 2012 Jun 22;423(1):60-6. doi: 10.1016/j.bbrc.2012.05.081. Epub 2012 May 22.


HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression.

Li Y, Bavarva JH, Wang Z, Guo J, Qian C, Thibodeau SN, Golemis EA, Liu W.

Oncogene. 2011 Jun 9;30(23):2633-43. doi: 10.1038/onc.2010.632. Epub 2011 Feb 14.


GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.

Wu J, Xie N, Xie K, Zeng J, Cheng L, Lei Y, Liu Y, Song L, Dong D, Chen Y, Zeng R, Nice EC, Huang C, Wei Y.

Carcinogenesis. 2013 Dec;34(12):2861-9. doi: 10.1093/carcin/bgt229. Epub 2013 Jun 26.


Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/β-catenin signal pathway.

Ji Q, Liu X, Fu X, Zhang L, Sui H, Zhou L, Sun J, Cai J, Qin J, Ren J, Li Q.

PLoS One. 2013 Nov 11;8(11):e78700. doi: 10.1371/journal.pone.0078700. eCollection 2013.


Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells.

Cormier K, Harquail J, Ouellette RJ, Tessier PA, Guerrette R, Robichaud GA.

Anticancer Agents Med Chem. 2014 Jan;14(1):35-45.


Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer.

Grebhardt S, Veltkamp C, Ströbel P, Mayer D.

Int J Cancer. 2012 Dec 15;131(12):2785-94. doi: 10.1002/ijc.27591. Epub 2012 May 8.


Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4.

Schelbergen RF, Blom AB, van den Bosch MH, Slöetjes A, Abdollahi-Roodsaz S, Schreurs BW, Mort JS, Vogl T, Roth J, van den Berg WB, van Lent PL.

Arthritis Rheum. 2012 May;64(5):1477-87. doi: 10.1002/art.33495.


Presence of S100A9-positive inflammatory cells in cancer tissues correlates with an early stage cancer and a better prognosis in patients with gastric cancer.

Fan B, Zhang LH, Jia YN, Zhong XY, Liu YQ, Cheng XJ, Wang XH, Xing XF, Hu Y, Li YA, Du H, Zhao W, Niu ZJ, Lu AP, Li JY, Ji JF.

BMC Cancer. 2012 Jul 28;12:316. doi: 10.1186/1471-2407-12-316.


Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling.

Herbst A, Jurinovic V, Krebs S, Thieme SE, Blum H, Göke B, Kolligs FT.

BMC Genomics. 2014 Jan 28;15:74. doi: 10.1186/1471-2164-15-74.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk